{
    "Overall_score": {
        "Correlation": 8,
        "Sentiment": 5,
        "Importance": 7,
        "Impact": 6,
        "Duration": 4,
        "Virality": 3,
        "Source_Score": 7,
        "Specificity": 8,
        "Sector_Spread": 6,
        "Tech_Mentions": 2
    },
    "Each_item": [
        {
            "News_content": "EARNINGS ALERT: Amgen Q1 EPS $1.87 ex-items vs. $1.94 Est.; Q1 Revs. $4.52B vs. $4.76B Est.",
            "Correlation": 10,
            "Sentiment": 3,
            "Importance": 8,
            "Impact": 7,
            "Duration": 3,
            "Virality": 4,
            "Source_Score": 8,
            "Specificity": 10,
            "Sector_Spread": 5,
            "Tech_Mentions": 1
        },
        {
            "News_content": "Amgen earnings miss with Kyprolis, not good for $LGND due to royalty on Kyprolis",
            "Correlation": 9,
            "Sentiment": 2,
            "Importance": 7,
            "Impact": 6,
            "Duration": 4,
            "Virality": 3,
            "Source_Score": 7,
            "Specificity": 9,
            "Sector_Spread": 4,
            "Tech_Mentions": 1
        },
        {
            "News_content": "$AMGN misses the Estimize EPS Consensus by 9c and the Estimize Revenue Consensus by $248.58M",
            "Correlation": 10,
            "Sentiment": 3,
            "Importance": 8,
            "Impact": 7,
            "Duration": 3,
            "Virality": 4,
            "Source_Score": 8,
            "Specificity": 10,
            "Sector_Spread": 5,
            "Tech_Mentions": 1
        },
        {
            "News_content": "$IBB up 3% ahead of health, biotech earnings season including $GILD, $ISRG, and $AMGN",
            "Correlation": 7,
            "Sentiment": 6,
            "Importance": 6,
            "Impact": 5,
            "Duration": 5,
            "Virality": 3,
            "Source_Score": 7,
            "Specificity": 7,
            "Sector_Spread": 8,
            "Tech_Mentions": 1
        },
        {
            "News_content": "Small-cap stocks breaking 52-wk high prices include $FTI, $IVZ, $AMGN, $GRPN",
            "Correlation": 6,
            "Sentiment": 7,
            "Importance": 5,
            "Impact": 4,
            "Duration": 6,
            "Virality": 2,
            "Source_Score": 6,
            "Specificity": 7,
            "Sector_Spread": 7,
            "Tech_Mentions": 2
        }
    ]
}